Premier Perspectives The blog for insider insights in clinical development Recent Posts By expertise area All expertise areas Medical DeviceRare DiseaseOncology & HematologyDiagnosticsDigital TherapeuticsMedTechPediatricsNeuroscienceAnalgesiaDermatologyOtherCOVID-19Cell & Gene TherapyWomen's HealthReal-World & Late PhaseLife at Premier By functional area All functional areas Development StrategyClinical Research: Phase 1 - Phase 4ConsultingData Management & BiostatisticsFunctional Service Provider (FSP)Global ComplianceMedical and Regulatory AffairsPatient and Stakeholder EngagementProject ManagementQualityReal-World Science and Late PhaseSafety/PharmacovigilanceStudy DesignStudy Start-UpOtherCOVID-19Product Development Clinical ResearchPhase 1 - Phase 4 Operational Challenges of Neuroscience Clinical Trials, Part 3: Patient Recruitment By Krista Armstrong August 28, 2018 Clinical ResearchPhase 1 - Phase 4 Operational Challenges of Neuroscience Clinical Trials, Part 2: High Placebo Responses By Krista Armstrong August 21, 2018 Clinical ResearchPhase 1 - Phase 4 5 Must-Dos To Build Trust Between an Early-Stage Biotech and CRO By Premier Research August 16, 2018 Clinical ResearchPhase 1 - Phase 4 Operational Challenges of Neuroscience Clinical Trials, Part 1: Overview By Krista Armstrong August 14, 2018 Medical and Regulatory Affairs The Ongoing Quest for Evidence on the Health Effects of Cannabis and Cannabis-Derived Products By Premier Research August 9, 2018 Medical and Regulatory Affairs Current Challenges (and Solutions) in Global Regulatory Harmonization By Premier Research August 7, 2018 Previous 1 …29 30 31 32 33 … 57 Next × ALSO OF INTERESTKey Considerations When Designing a Phase 1...Nostalgia or Shell Shock? Assessing PTSD Is a...Gene Therapy 101: From the 1960s to Today